The XC rat sarcoma cell line undergoes extensive cell-to-cell fusion (syncytium formation) after infection with ecotropic murine leukemia viruses (MLVs) and is frequently used to titrate these viruses. This cell line is unique in its response to the ecotropic MLV envelope (Env) protein in that it undergoes syncytium formation with cells expressing Env protein containing R peptide (Rϩ Env), which is known to suppress the fusogenic potential of the Env protein in other susceptible cells. To assess whether this property of the XC cell line arises from differences in its ecotropic MLV receptor, CAT1, we isolated CAT1 cDNA clones from XC cells. A variant CAT1 (xcCAT1) was found together with the wild-type rat CAT1 (rCAT1). xcCAT1 cDNA encodes a protein with a single amino acid change that destroys a conserved N-linked glycosylation site proximal to the Env-binding motif. We found that xcCAT1 expressed in Chinese hamster ovary (CHO) cells undergoes less glycosylation than rCAT1 and that the expression of xcCAT1 rendered the CHO cells more susceptible to infection with Moloney MLV. Thus, N-glycosylation negatively regulates the receptor activity of rCAT1. This is supported by the observation that treatment of rat F10 cells with the N-glycosylation inhibitor tunicamycin enhanced their susceptibility to Mo-MLV. However, xcCAT1expressing CHO cells did not fuse with 293T cells expressing Rϩ Env, indicating that xcCAT1 expression is not sufficient to induce the XC cell-specific characteristic of forming syncytia in response to Rϩ Env. © 2002 Elsevier Science (USA) 
INTRODUCTION
Entry of enveloped viruses into host cells is initiated by binding of the viral envelope protein to the cellular receptor for infection, after which the viral envelope fuses with cellular membranes (Chan and Kim, 1998; Skehel and Wiley, 1998; White, 1992) . The envelope (Env) protein of the ecotropic Moloney murine leukemia virus (Mo-MLV) is synthesized as a precursor polyprotein and is proteolytically cleaved into surface and transmembrane (TM) subunits during its transport to the cell surface (Schult and Rein, 1985) . The C-terminal 16 amino acids (R peptide) of the TM protein is further cleaved in the virions by the viral protease (Green et al., 1981; Henderson et al., 1984) . The R peptide appears to negatively control the membrane fusion activity of the Env protein as the Mo-MLV Env protein genetically engineered to lose the R peptide (R-Env) causes receptor-mediated syncytium formation when expressed in susceptible cells, unlike the wild-type Env protein bearing the R peptide (Rϩ Env) (Melikyan et al., 2000; Ragheb and Anderson, 1994; Rein et al., 1994) . Such syncytium formation is thought to correspond to the fusion between the viral envelope and the host cell membranes that precedes viral entry.
The rat XC cell line, which was established from a Raus sarcoma virus-induced tumor, differs from other lines in that it undergoes syncytium formation in response to the Rϩ Env protein (Jones and Risser, 1993) . Consequently, the XC cell line is widely used to titrate ecotropic MLVs, as the number of plaques resulting from the syncytium formation correlates with the viral titer (Klement et al., 1969; Rowe et al., 1970) . Why the XC cell line has this unique property is unclear. One possibility is that its ecotropic MLV receptor, CAT1 (cationic amino acid transporter 1) (Albritton et al., 1989) , differs in some way. In the study reported here, we have investigated this issue by cloning and characterizing cDNAs from XC cells that encode CAT1. In addition to the wild-type rat CAT1 (rCAT1) previously reported (Takase-Yoden and Watanabe, 1999; Wu et al., 1994) , we obtained clones encoding a variant form of rCAT1. This variant, denoted xcCAT1, contained a single amino acid substitution that abolished the conserved consensus sequence for Nlinked glycosylation near the Env-binding motif (Albritton et al., 1993; Yoshimoto et al., 1993) . xcCAT1 expression in Chinese hamster ovary (CHO) cells increased their susceptibility to the Mo-MLV vector relative to rCAT1 expres-sion. These and other observations (Tavoloni and Rudenholz, 1997 ) collectively indicate that the N-glycosylation of rCAT1 downregulates its ecotropic receptor activity. Thus, XC cells are more susceptible to the first stage of Mo-MLV infection, namely, the binding of the virus to its ecotropic receptor. However, we also found that xcCAT1expressing CHO cells fused with RϪ Env-expressing 293T cells and formed syncytia but not with Rϩ Envexpressing cells. Thus, xcCAT1 expression is not sufficient to endow the XC cell-specific characteristic of forming syncytia in response to Rϩ Env.
RESULTS

Isolation of CAT1 cDNA clones from XC cells
CAT1 cDNA clones were isolated from rat XC cells by the RT-PCR method. The PCR primers were based on the published nucleotide sequence of rCAT1 cDNA (Takase-Yoden and Watanabe, 1999; Wu et al., 1994) . The sense and antisense PCR primers contained the translation initiation and the termination codons, respectively, but not the sequences coding for the rest of the rCAT1 protein. The nucleotide sequences of two cDNA clones were determined. Both contained an open reading frame encoding a protein of 624 amino acids, the same number of amino acids as the rCAT1 protein. One clone (clone 1) had eight nucleotides that differed from the reported sequence of rCAT1 cDNA and the deduced amino acid sequence had a single amino acid change from the rCAT1 protein. The other clone (clone 2) had seven nu-cleotide changes that did not cause amino acid changes and also occurred in clone 1. Thus, the nucleotide change unique to clone 1 resulted in the single amino acid substitution of Asn 231 by Asp (Fig. 1) . The CAT1 cDNA of clone 1 is designated here as xcCAT1.
To confirm that the unique nucleotide change found in xcCAT1 cDNA was not an artifact caused by the isolation procedures we used, including reverse transcription and PCR, additional cDNA clones encompassing the 171-bp sequence of rCAT1 that included the site of the unique nucleotide change were independently isolated from XC cells by RT-PCR. The nucleotide sequences of 12 clones were determined. Three had the same unique nucleotide change (A to G) as xcCAT1, while the other clones had the same sequence as clone 2 (data not shown). Thus, XC cells express a variant form of rCAT1 (xcCAT1) as well as the wild-type rCAT1.
The Asn 231 residue of rCAT1 is located in the putative third extracellular loop and participates in the consensus sequence (N-X-T/S) for N-linked glycosylation. This Nglycosylation site and another site located several amino acids upstream toward the N-terminus are conserved in the CAT1 proteins from many species, including mice (Albritton et al., 1989) , Mus dunni, Chinese hamsters, Syrian hamsters (Eiden et al., 1993 (Eiden et al., , 1994 , Armenian hamsters (Masuda et al., 1996a) , mink, and humans (Yoshimoto et al., 1991) ( Fig. 1 ). The N231D change in xc-CAT1 will thus most likely result in loss of glycosylation at this site. 
xcCAT1 undergoes less glycosylation than rCAT1
The N231D change suggests that the xcCAT1 glycoprotein will be smaller than rCAT1. To assess this, expression plasmids encoding rCAT1, xcCAT1, and mouse CAT1 (mCAT1) tagged with an influenza hemagglutinin (HA) epitope were constructed, CHO cells were transfected, and Western blot analysis with the anti-HA epitope monoclonal antibody was performed. As shown in Fig. 2 , the xcCAT1 protein was significantly smaller than the mCAT1 and rCAT1 proteins. However, treatment of the three transfected CHO cell types with the N-glycosylation inhibitor tunicamycin resulted in faster moving CAT1 protein bands of a equivalent molecular size (Fig. 2) . Thus, the N231D substitution indeed prevents the full N-glycosylation of xcCAT1.
xcCAT1-expressing CHO cells are more susceptible to Mo-MLV vector transduction than rCAT1-expressing cells
We investigated whether expressing xcCAT1 would make the host cells more susceptible to Mo-MLV vector transduction. We tested this by measuring the transduction titer of the Mo-MLV vector in CHO cells transiently transfected with various amounts of the HA-tagged rCAT1 or xcCAT1 expression plasmids. For both plasmids, the levels of CAT1 protein expressed depended on the plasmid dose ( Fig. 3) .
Higher amounts of the xcCAT1-HA expression plasmid induced higher transduction titer in the range from 0.1 to 1.0 g of the plasmid (Fig. 4) . Although the highest level of xcCAT1-HA protein was detected in CHO cells transfected with 3.0 g of the expression plasmid, transduction titer of Mo-MLV vector in those cells was lowest. Transduction titer in CHO cells transfected with 0.5 g of the rCAT1-HA expression plasmid was higher than in 0.1 g of the plasmid. Higher amounts of the rCAT1-HA expression plasmid, however, induced lower transduction titer of Mo-MLV vector in the range from 0.5 to 3.0 g of the plasmid. This result suggests that a higher amount
xcCAT is less glycosylated than rCAT1. CHO cells transiently transfected with the HA epitope-tagged mCAT1, rCAT1, and xcCAT1 constructs were cultured in the absence or presence of tunicamycin for 48 h. Cell lysates were prepared and analyzed by Western blotting using the anti-HA epitope monoclonal antibody. CHO cells transfected with the pUC plasmid were used as controls. of the plasmids damages CHO cells more severely and induces lower transduction titer of Mo-MLV vector.
The transduction titer in CHO cells transfected with 0.5 g of rCAT1-HA expression plasmid was lower than that with 0.1 g xcCAT1-HA expression plasmid, even though the amount of rCAT1-HA protein was clearly higher than that of xcCAT1-HA. This result indicates that xcCAT1 is more susceptible to Mo-MLV vector transduction than rCAT1.
The xcCAT1-HA-expressing CHO cells fused with RϪ Env-expressing human 293T cells and formed syncytia, but did not with Rϩ Env-expressing cells (data not shown). This result indicates that the xcCAT1 is not sufficient for the XC cell-specific syncytium formation by Rϩ Env protein.
Tunicamycin treatment makes F10 cells more susceptible to Mo-MLV
The observations above suggest that N-glycosylation at the site proximal to the Env-binding motif downregulates the ability of rCAT1 to function as the ecotropic MLV receptor. Supporting this notion is that treatment of hamster cells, such as CHO, BHK (Karreman et al., 1996; Miller and Miller, 1992) , and THK (T. Ono and A. Ishimoto, unpublished observations), with the N-glycosylation inhibitors tunicamycin or sialidase makes the cells susceptible to Mo-MLV infection. Furthermore, some CHO cell glycosylation mutants are also susceptible to Mo-MLV infection (Eiden et al., 1994) . Thus, we assessed whether treating rat F10 cells with tunicamycin would render these cells more susceptible to Mo-MLV. As shown in Fig. 5 , transduction titers in tunicamycintreated F10 cells were significantly increased compared to the titers in nontreated F10 cells. In contrast, the transduction titers in NIH 3T3 and XC cells were not increased by tunicamycin treatment. Thus, the N-linked glycosylation downmodulates the viral receptor activity of rCAT1.
Tunicamycin-treated F10 cells cultured with RϪ Envexpressing 293T cells formed syncytia, but did not with Rϩ Env-expressing cells (data not shown). This result supports the result that xcCAT1 expression is not sufficient to endow the XC cell-specific characteristic of forming syncytia in response to Rϩ Env.
DISCUSSION
N-glycosylation near the Env-binding motif of the rat ecotropic MLV receptor downregulates virus binding CAT1 is the ecotropic MLV receptor. When we performed RT-PCR on mRNA prepared from rat XC cells to clone CAT1 cDNA, we isolated a clone encoding a variant of CAT1 cDNA, denoted xcCAT1. The xcCAT1 protein has a single amino acid substitution at the N-linked glycosylation site near the Env-binding motif (Albritton et al., 1993; Yoshimoto et al., 1993) (Fig. 1) . Western blotting analysis revealed that xcCAT1 is a smaller glycoprotein than the wild-type rCAT1 glycoprotein due to its reduced glycosylation (Fig. 2) . xcCAT1 expression increased the susceptibility to Mo-MLV vector transduction relative to rCAT1 in CHO cells (Fig. 4) and treatment of rat F10 cells with the N-glycosylation inhibitor tunicamycin rendered these cells more susceptible to Mo-MLV entry (Fig. 5) . Thus, the N-glycosylation at the Asn 231 residue of the wild-type rCAT1 negatively regulates Mo-MLV infection. This notion is supported by previously published observations that tunicamycin or sialidase treatment renders hamster and rat cells more susceptible to the Mo-MLV infection (Tavoloni and Rudenholz, 1997; Karreman et al., 1996; Miller and Miller, 1992; Wilson and Eiden, 1991) , and that glycosylation mutants of the CHO cell line are susceptible to Mo-MLV infection (Eiden et al., 1994) .
It is possible that the N-glycosylation of CAT1 has arisen as a defense against ecotropic MLV infection, especially since it appears that the N-glycosylation sites of CAT1 do not participate in the primary cationic amino acid transporter function of this protein. This is shown by the fact that mCAT1 mutants with amino acid substitutions at the N-linked glycosylation site are equally active cationic amino acid transporters as the wild-type mCAT1 (Wang et al., 1996) . It has also been reported that coreceptor glycosylation modulates the susceptibility of cells to human immunodeficiency viruses (Chabot et al., 2000; Potempa et al., 1997; Talbot et al., 1995) .
How N-glycosylation could affect susceptibility to Mo-MLV is not clear, although it most likely abrogates or reduces the binding of the receptor to the Env protein of Mo-MLV. It is unlikely that it regulates the cell-surface expression of the receptor because previous studies have shown that the cell-surface expression of the CAT1 protein of mice and M. dunni is not inhibited by artificial mutations that abrogate N-glycosylation Wang et al., 1996; Eiden et al., 1994) . Tunicamycin treatment of hamster cells also does not reduce CAT1 protein expression on the cell surface (Miller and Miller, 1992; Wilson and Eiden, 1991) .
It should be noted that some published observations suggest that N-glycosylation of CAT1 may not be the only factor regulating Mo-MLV infection. First, while hamster cells are almost completely resistant to Mo-MLV infection (Wilson and Eiden, 1991) , rat F10 cells are slightly susceptible (Takase-Yoden and Watanabe, 1999) , despite the fact that the CAT1 from rats and hamsters share the same conserved N-glycosylation sites. Furthermore, mouse cells, which also have the conserved N-glycosylation sites, are highly susceptible to ecotropic MLV infection ( Fig. 1) and artificial substitutions at these sites that abrogate glycosylation of the mouse receptor do not alter the in vitro susceptibility of the cells to MLV infection Wang et al., 1996) . However, it is possible that different degrees of glycosylation of the receptor in different cell types may be responsible for the cell-type specific susceptibilities to infection with ecotropic MLVs in vivo. Isolating CAT1 cDNA clones from many other species and performing functional analysis may better clarify the purpose of the N-glycosylation sites in CAT1.
Notably, N-glycosylation of CAT1 appears to have no effect on infection with the closely related Friend MLV (Fr-MLV). It has been reported that while the N-glycosylation of M. dunni CAT1 inhibits infection with Mo-MLV, the cells remain susceptible to infection with Fr-MLV (Eiden et al., 1993 (Eiden et al., , 1994 . Furthermore, Fr-MLV can infect hamster cells (Ishimoto, 1985) , which are completely resistant to Mo-MLV infection (Wilson and Eiden, 1991) . In addition, neuropathogenic MLVs derived from Fr-MLV (Kai and Furuta, 1984; Masuda et al., 1992; Takase-Yoden and Watanabe, 1997) are known to infect hamster and rat cells more efficiently than non-neuropathogenic MLVs (Masuda et al., 1996a,b; Takase-Yoden and Watanabe, 1999) . This indicates that Fr-MLV, together with neuropathogenic MLVs, may have evolved a mechanism to overcome the inhibition imposed by receptor glycosylation.
Role of xcCAT1 in XC cells
It is clear that the presence of xcCAT1 increases the susceptibility of the host cells to Mo-MLV infection. We do not know whether the rat from which the XC cell line was derived expressed xcCAT1 or if xcCAT1 appeared during the cellular transformation by the Raus sarcoma virus or during the maintenance of the XC cell line. However, it is clear that the unique nucleotide change we found in the xcCAT1 cDNA did not result from the cDNA isolation procedures that we used since we could isolate several independent RT-PCR clones with the same nucleotide change. Furthermore, that tunicamycin treatment of XC cells did not increase their susceptibility to Mo-MLV infection (Fig. 5 ) strongly supports the notion that XC cells express xcCAT1.
It is curious that tunicamycin treatment of XC cells does not increase their susceptibility to Mo-MLV infection, as these cells express rCAT1 as well as xcCAT1. It may be that the available xcCAT1 saturates the receptor activity of the cell. This is supported by the observation that CHO cells expressing low levels of xcCAT1 protein were transduced efficiently by Mo-MLV vector (Figs. 3  and 4 ).
Syncytium formation in XC cells by the Rϩ Env protein
XC cells are unusual in that they form syncytia in response to both the RϪ and the Rϩ Env proteins. Normally, the membrane-fusion potential of the Env protein is activated only after R peptide cleavage (Melikyan et al., 2000; Ragheb and Anderson, 1994; Rein et al., 1994) . Thus, in cells such as NIH 3T3 and F10, only the RϪ Env protein, not the Rϩ Env protein, induces syncytium formation. We initiated our investigation of the CAT1 isolated from XC cells to determine why XC cells can form syncytia in response to the Rϩ Env protein. We found that CHO cells expressing xcCAT1 formed syncytia when they were cultured with RϪ Env-expressing 293T cells but not when they were cultured with Rϩ Envexpressing 293T cells. Thus, xcCAT1 expression is not sufficient to endow the XC cell-specific property of forming syncytia in response to the Rϩ Env protein. However, as xcCAT1-expressing cells are obviously more susceptible to ecotropic MLV infection than rCAT1-expressing cells, it is still possible that xcCAT1 could contribute to the Rϩ Env protein-induced syncytium formation of XC cells. However, there are clearly also other factors in the XC cell line that are responsible for its exceptional response to the Rϩ Env protein. Further studies on this issue may aid our understanding of the mechanisms by which Env protein-mediated membrane fusion occur and how the CAT1 protein is regulated as a viral receptor.
MATERIALS AND METHODS
CAT1 cDNA clones
CAT1 cDNA was cloned from XC cells by the RT-PCR method using LA Taq DNA polymerase (Takara) and the R1 and R2 primers. Total RNA was extracted from XC cells and used for random oligonucleotide-primed reverse transcription to produce the single-stranded cDNAs (LA RNA PCR kit, Takara). The sequences of the R1 and R2 primers were 5Ј-TTACTGCAGACAGATTTGCT-CAGCGCGATG-3Ј and 5Ј-TGTCACCTTGGTGGGTGGGG-CTGTGGGTCA-3Ј, respectively. The LA Taq DNA poly-merase has a proofreading activity and high fidelity (Barnes, 1994; Cheng et al., 1994) . The PCR primers were synthesized by Nisshinbo Inc. according to the reported sequence of rCAT1 (Takase-Yoden and Watanabe, 1999; Wu et al., 1994) . The PCR products were inserted into the pTargeT expression vector (Promega) by TA ligation. Nucleotide sequences were determined using the ABI PRISM 377 sequencer at Fasmac Co. For cDNA cloning of a portion of rCAT1 from XC cells by the RT-PCR method, R3 (5Ј-AAATCCAGTCCTCTCTGTGGGAAC-3Ј) and R4 (5Ј-CTTCTGGGGGTTCTTGACTTCTTC-3Ј) were used. These primers were designed to amplify the sequence encoding a segment of the putative third extracellular loop of rCAT1. Cloned cDNAs for rCAT1 (Takase-Yoden and Watanabe, 1999) and mCAT1 (Albritton et al., 1989) were kindly provided by R. Watanabe (Soka University, Tokyo) and J. M. Cunningham (Harvard Medical School, MA), respectively. Expression plasmids for mCAT1, rCAT1, and xcCAT1 tagged with the HA epitope were constructed by the PCR-mediated method using the following primers: 5Ј-TTACTGCAGACAGATTTGCTCA-GCGCGATG-3Ј and 5Ј-TCATGCGTAATCCGGAACATCGT-ACGGGTATTTGCACTGGTCCAAGTTGCTGTCAGGAGTC-TT-3Ј. The latter antisense primer contains the HA epitope sequence.
Cell growth, transfection, and tunicamycin treatment
Mouse embryo fibroblast NIH 3T3, rat glial F10 (Sun, 1991) , rat sarcoma XC, human embryo kidney 293T, and human TELCeB6 (Cosset et al., 1995) cells were cultured in Dulbecco's modified Eagle's medium (Sigma) at 37°C in 5% CO 2 . Chinese hamster ovary fibroblast CHO-K1 cells were cultured in Ham's F-12 nutrient mixture medium (Gibco-BRL). The culture media were all supplemented with 8% fetal bovine serum (FBS) (HyClone).
For analysis of the molecular weights of the HA epitope-tagged CAT1 proteins, semiconfluent cultures of CHO cells were transfected for 48 h in the presence or absence of 100 ng/ml tunicamycin (Sigma) with each of the HA-tagged CAT1 expression plasmids using the TransIT-LT1 polyamine reagent (Mirus). Cell lysates were then prepared by the RIPA buffer on ice and aliquots containing 70 g protein were subjected to 7.5% SDSpolyacrylamide gel electrophoresis and subsequent Western blotting using the mouse anti-HA epitope monoclonal antibody (1:2000 dilution) (Covance) and horseradish peroxidase (HRP)-conjugated anti-mouse IgG (Bio-Rad).
To determine the susceptibility of transfected CHO cells to the ecotropic virus vector, 24 h after inoculation of 1 ϫ 10 5 CHO cells into 60-mm dishes, the cells were transfected with various amounts of the TransIT-DNA complexes and 24 h later used for transduction assays (see below).
To assess the effect of tunicamycin treatment on the susceptibility of NIH 3T3, F10, and XC cells to the ecotropic virus vector, the cells (10 5 ) were seeded in 60-mm culture dishes and the following day, tunicamycin at the indicated final concentration was added. The culture medium was removed 24 h later and the cells were used for transduction assays (see below).
Transduction assay
The ecotropic retrovirus vector was generated by stable transfection of TELCeB6 cells, which express the Mo-MLV gag and pol genes and the retroviral vector genome containing Escherichia coli lacZ (Cosset et al., 1995) , with the wild-type Mo-MLV Env expression plasmid. Cultures of NIH 3T3, F10, XC, CHO, and transfected CHO cells were exposed to the virus vector for 24 h in the presence of polybrene (4 g/ml). After culturing for an additional 24 h in fresh medium, the cells were stained with 5-bromo-4-chloro-3-indolyl ␤-D-galactopyranoside (X-Gal), and the blue cells were counted under a microscope to estimate the transduction titer.
Syncytium formation assay
The expression plasmids encoding the wild-type Mo-MLV Env protein (Rϩ Env) or Env lacking the R peptide (RϪ Env) were transfected into 293T cells using the TransIT-LT1 reagent. The plasmid encoding the RϪ Env protein was constructed by the PCR-based method using a mutant oligonucleotide that substitutes the codon for valine at amino acid position 617 by the termination codon. Two days after transfection, aliquots of the 293T cells were inoculated onto confluent cultures of the target cells. These cells were fixed and stained with 1% methylene blue in methanol 24 h later.
